Study Summary
This trial seeks to reduce HIV & syphilis in rural OK men, by increasing testing, condom use & PrEP uptake. It will refine an intervention in partnership with local mentors & assess its impact.
- HIV/AIDS
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: 1 month and 3 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
e-HERO 1.0
1 of 2
e-HERO 2.0
1 of 2
Active Control
Experimental Treatment
200 Total Participants · 2 Treatment Groups
Primary Treatment: e-HERO 2.0 · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 17 - 29 · Male Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Who qualifies to participate in the experiment?
"Eligible candidates for this clinical trial must have HIV and fall between the ages of 17-29. Approximately 200 patients are needed to fulfill the goal of this project." - Anonymous Online Contributor
Are individuals over 45 years old eligible to join this research endeavor?
"The eligibility criteria of this clinical trial necessitates that participants must be between the ages of 17 and 29. In comparison, there are 149 studies for minors under 18 years old and 470 trials for senior citizens 65 or older." - Anonymous Online Contributor
What is the number of participants involved in this clinical experiment?
"Affirmative. Clinicaltrials.gov attests that this clinical trial is currently recruiting individuals with the first posting of December 1st 2022 and a recent update on December 16th 2022. 200 volunteers need to be enrolled from one medical centre for the study's completion." - Anonymous Online Contributor
Is recruitment currently underway for this trial?
"Affirmative. Documents posted to clinicaltrials.gov demonstrate that this medical trial, which was initially published on December 1st 2022, is presently seeking participants. Approximately 200 patients have been identified as necessary for the study across a single site." - Anonymous Online Contributor